The global mRNA Vaccine And Therapeutics market is projected to grow from US$ 38750 million in 2024 to US$ 51630 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.

mRNA Vaccine And Therapeutics Market

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Market Analysis and Insights: Global mRNA Vaccine And Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for mRNA Vaccine And Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of mRNA Vaccine And Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Vaccine And Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the mRNA Vaccine And Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Vaccine And Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for mRNA Vaccine And Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of mRNA Vaccine And Therapeutics Market Report

Report Metric	Details
Report Name	mRNA Vaccine And Therapeutics Market
Accounted market size in 2024	US$ 38750 in million
Forecasted market size in 2030	US$ 51630 million
CAGR	4.9
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Infectious Disease Cancer Others
Segment by Application	Hospital Research Institual
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology, Translate Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Vaccine And Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccine And Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccine And Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is mRNA Vaccine And Therapeutics Market growing?

Ans: The mRNA Vaccine And Therapeutics Market witnessing a CAGR of 4.9 during the forecast period 2025-2030.

What is the mRNA Vaccine And Therapeutics Market size in 2030?

Ans: The mRNA Vaccine And Therapeutics Market size in 2030 will be US$ 51630 million.

Who are the main players in the mRNA Vaccine And Therapeutics Market report?

Ans: The main players in the mRNA Vaccine And Therapeutics Market are Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology, Translate Bio

What are the Application segmentation covered in the mRNA Vaccine And Therapeutics Market report?

Ans: The Applications covered in the mRNA Vaccine And Therapeutics Market report are Hospital, Research Institual

What are the Type segmentation covered in the mRNA Vaccine And Therapeutics Market report?

Ans: The Types covered in the mRNA Vaccine And Therapeutics Market report are Infectious Disease, Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Infectious Disease

1.2.3 Cancer

1.2.4 Others

1.3 Market by Application

1.3.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Research Institual

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2019-2030)

2.2 Global mRNA Vaccine And Therapeutics Growth Trends by Region

2.2.1 mRNA Vaccine And Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 mRNA Vaccine And Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 mRNA Vaccine And Therapeutics Market Dynamics

2.3.1 mRNA Vaccine And Therapeutics Industry Trends

2.3.2 mRNA Vaccine And Therapeutics Market Drivers

2.3.3 mRNA Vaccine And Therapeutics Market Challenges

2.3.4 mRNA Vaccine And Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue mRNA Vaccine And Therapeutics by Players

3.1.1 Global mRNA Vaccine And Therapeutics Revenue by Players (2019-2024)

3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of mRNA Vaccine And Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio

3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2023

3.5 Global Key Players of mRNA Vaccine And Therapeutics Head office and Area Served

3.6 Global Key Players of mRNA Vaccine And Therapeutics, Product and Application

3.7 Global Key Players of mRNA Vaccine And Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Vaccine And Therapeutics Breakdown Data by Type

4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2025-2030)

5 mRNA Vaccine And Therapeutics Breakdown Data by Application

5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America mRNA Vaccine And Therapeutics Market Size (2019-2030)

6.2 North America mRNA Vaccine And Therapeutics Market Size by Type

6.2.1 North America mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)

6.2.2 North America mRNA Vaccine And Therapeutics Market Size by Type (2025-2030)

6.2.3 North America mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

6.3 North America mRNA Vaccine And Therapeutics Market Size by Application

6.3.1 North America mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)

6.3.2 North America mRNA Vaccine And Therapeutics Market Size by Application (2025-2030)

6.3.3 North America mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

6.4 North America mRNA Vaccine And Therapeutics Market Size by Country

6.4.1 North America mRNA Vaccine And Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

6.4.3 North America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe mRNA Vaccine And Therapeutics Market Size (2019-2030)

7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type

7.2.1 Europe mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application

7.3.1 Europe mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe mRNA Vaccine And Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country

7.4.1 Europe mRNA Vaccine And Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China mRNA Vaccine And Therapeutics Market Size (2019-2030)

8.2 China mRNA Vaccine And Therapeutics Market Size by Type

8.2.1 China mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)

8.2.2 China mRNA Vaccine And Therapeutics Market Size by Type (2025-2030)

8.2.3 China mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

8.3 China mRNA Vaccine And Therapeutics Market Size by Application

8.3.1 China mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)

8.3.2 China mRNA Vaccine And Therapeutics Market Size by Application (2025-2030)

8.3.3 China mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia mRNA Vaccine And Therapeutics Market Size (2019-2030)

9.2 Asia mRNA Vaccine And Therapeutics Market Size by Type

9.2.1 Asia mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia mRNA Vaccine And Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

9.3 Asia mRNA Vaccine And Therapeutics Market Size by Application

9.3.1 Asia mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia mRNA Vaccine And Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

9.4 Asia mRNA Vaccine And Therapeutics Market Size by Region

9.4.1 Asia mRNA Vaccine And Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia mRNA Vaccine And Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia mRNA Vaccine And Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Argos Therapeutics

11.1.1 Argos Therapeutics Company Details

11.1.2 Argos Therapeutics Business Overview

11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction

11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.1.5 Argos Therapeutics Recent Developments

11.2 BioNTech

11.2.1 BioNTech Company Details

11.2.2 BioNTech Business Overview

11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction

11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.2.5 BioNTech Recent Developments

11.3 CureVac

11.3.1 CureVac Company Details

11.3.2 CureVac Business Overview

11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction

11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.3.5 CureVac Recent Developments

11.4 eTheRNA

11.4.1 eTheRNA Company Details

11.4.2 eTheRNA Business Overview

11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction

11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.4.5 eTheRNA Recent Developments

11.5 Ethris

11.5.1 Ethris Company Details

11.5.2 Ethris Business Overview

11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction

11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.5.5 Ethris Recent Developments

11.6 In-Cell-Art

11.6.1 In-Cell-Art Company Details

11.6.2 In-Cell-Art Business Overview

11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction

11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.6.5 In-Cell-Art Recent Developments

11.7 Moderna Therapeutics

11.7.1 Moderna Therapeutics Company Details

11.7.2 Moderna Therapeutics Business Overview

11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction

11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.7.5 Moderna Therapeutics Recent Developments

11.8 Sangamo Therapeutics

11.8.1 Sangamo Therapeutics Company Details

11.8.2 Sangamo Therapeutics Business Overview

11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction

11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.8.5 Sangamo Therapeutics Recent Developments

11.9 Tiba Biotechnology

11.9.1 Tiba Biotechnology Company Details

11.9.2 Tiba Biotechnology Business Overview

11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction

11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.9.5 Tiba Biotechnology Recent Developments

11.10 Translate Bio

11.10.1 Translate Bio Company Details

11.10.2 Translate Bio Business Overview

11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction

11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.10.5 Translate Bio Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Infectious Disease

Table 3. Key Players of Cancer

Table 4. Key Players of Others

Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global mRNA Vaccine And Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global mRNA Vaccine And Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global mRNA Vaccine And Therapeutics Market Share by Region (2019-2024)

Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global mRNA Vaccine And Therapeutics Market Share by Region (2025-2030)

Table 11. mRNA Vaccine And Therapeutics Market Trends

Table 12. mRNA Vaccine And Therapeutics Market Drivers

Table 13. mRNA Vaccine And Therapeutics Market Challenges

Table 14. mRNA Vaccine And Therapeutics Market Restraints

Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global mRNA Vaccine And Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top mRNA Vaccine And Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2023)

Table 18. Global mRNA Vaccine And Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of mRNA Vaccine And Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of mRNA Vaccine And Therapeutics, Product and Application

Table 22. Global Key Players of mRNA Vaccine And Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global mRNA Vaccine And Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global mRNA Vaccine And Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America mRNA Vaccine And Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America mRNA Vaccine And Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America mRNA Vaccine And Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe mRNA Vaccine And Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe mRNA Vaccine And Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe mRNA Vaccine And Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China mRNA Vaccine And Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China mRNA Vaccine And Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia mRNA Vaccine And Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia mRNA Vaccine And Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia mRNA Vaccine And Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia mRNA Vaccine And Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia mRNA Vaccine And Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Argos Therapeutics Company Details

Table 65. Argos Therapeutics Business Overview

Table 66. Argos Therapeutics mRNA Vaccine And Therapeutics Product

Table 67. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Argos Therapeutics Recent Developments

Table 69. BioNTech Company Details

Table 70. BioNTech Business Overview

Table 71. BioNTech mRNA Vaccine And Therapeutics Product

Table 72. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 73. BioNTech Recent Developments

Table 74. CureVac Company Details

Table 75. CureVac Business Overview

Table 76. CureVac mRNA Vaccine And Therapeutics Product

Table 77. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 78. CureVac Recent Developments

Table 79. eTheRNA Company Details

Table 80. eTheRNA Business Overview

Table 81. eTheRNA mRNA Vaccine And Therapeutics Product

Table 82. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 83. eTheRNA Recent Developments

Table 84. Ethris Company Details

Table 85. Ethris Business Overview

Table 86. Ethris mRNA Vaccine And Therapeutics Product

Table 87. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Ethris Recent Developments

Table 89. In-Cell-Art Company Details

Table 90. In-Cell-Art Business Overview

Table 91. In-Cell-Art mRNA Vaccine And Therapeutics Product

Table 92. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 93. In-Cell-Art Recent Developments

Table 94. Moderna Therapeutics Company Details

Table 95. Moderna Therapeutics Business Overview

Table 96. Moderna Therapeutics mRNA Vaccine And Therapeutics Product

Table 97. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Moderna Therapeutics Recent Developments

Table 99. Sangamo Therapeutics Company Details

Table 100. Sangamo Therapeutics Business Overview

Table 101. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product

Table 102. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Sangamo Therapeutics Recent Developments

Table 104. Tiba Biotechnology Company Details

Table 105. Tiba Biotechnology Business Overview

Table 106. Tiba Biotechnology mRNA Vaccine And Therapeutics Product

Table 107. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Tiba Biotechnology Recent Developments

Table 109. Translate Bio Company Details

Table 110. Translate Bio Business Overview

Table 111. Translate Bio mRNA Vaccine And Therapeutics Product

Table 112. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 113. Translate Bio Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global mRNA Vaccine And Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Infectious Disease Features

Figure 4. Cancer Features

Figure 5. Others Features

Figure 6. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global mRNA Vaccine And Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Research Institual Case Studies

Figure 10. mRNA Vaccine And Therapeutics Report Years Considered

Figure 11. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global mRNA Vaccine And Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global mRNA Vaccine And Therapeutics Market Share by Players in 2023

Figure 15. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2023

Figure 17. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

Figure 19. North America mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

Figure 20. North America mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 21. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe mRNA Vaccine And Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

Figure 25. Europe mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

Figure 26. Europe mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China mRNA Vaccine And Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

Figure 35. China mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

Figure 36. Asia mRNA Vaccine And Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

Figure 38. Asia mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia mRNA Vaccine And Therapeutics Market Share by Region (2019-2030)

Figure 40. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 50. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 57. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 58. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 59. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 60. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 61. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 62. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 63. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 64. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 65. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-18158

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Peptide Synthesis Reagents Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30P13579

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Human Skeletal Muscle Cells (SkMC) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3V13566

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Bovine Pancreatic Trypsin Inhibitor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7Q14080

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global mRNA Vaccine And Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-10S14382

Global mRNA Vaccine And Therapeutics Market Insights, Forecast to 2030

FEATURED COMPANIES

mRNA Vaccine And Therapeutics Market Size

mRNA Vaccine And Therapeutics Market

Scope of mRNA Vaccine And Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is mRNA Vaccine And Therapeutics Market growing?

What is the mRNA Vaccine And Therapeutics Market size in 2030?

Who are the main players in the mRNA Vaccine And Therapeutics Market report?

What are the Application segmentation covered in the mRNA Vaccine And Therapeutics Market report?

What are the Type segmentation covered in the mRNA Vaccine And Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User